Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Sustainable Development01:43

Sustainable Development

15.1K
As the human population continues to grow and use resources, we must be mindful of our planet’s natural limits. Sustainable development provides a pathway to maintain and improve human life now while also ensuring that future generations will have the resources that they need. The long-term success of sustainability efforts rests on understanding the interplay between human actions and ecological systems.
15.1K
Development of the Lymphatic System01:15

Development of the Lymphatic System

2.1K
The development of lymphatic tissues and vessels in embryonic life begins around the fifth week. These structures originate from the mesoderm layer, with lymph sacs emerging from developing veins.
The first lymph sacs to form are the paired jugular lymph sacs located at the junction of the internal jugular and subclavian veins. From these sacs, lymphatic capillary plexuses extend to the thorax, upper limbs, neck, and head, eventually forming lymphatic vessels. Each jugular lymph sac maintains a...
2.1K
Language Development01:22

Language Development

911
Children master language quickly and with relative ease, supported by both biological predisposition and reinforcement. B. F. Skinner (1957) proposed that language is learned through reinforcement, while Noam Chomsky (1965) argued that language acquisition mechanisms are biologically determined.
The critical period for language acquisition suggests that the ability to acquire language is at its peak early in life. As people age, this proficiency decreases. Language development begins very...
911
Development of Immunocompetence01:22

Development of Immunocompetence

874
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
874
Development of the Heart01:27

Development of the Heart

2.4K
The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart...
2.4K
Fruit Development, Structure, and Function01:58

Fruit Development, Structure, and Function

25.2K
Fruits form from a mature flower ovary. As seeds develop from the ovules contained within, the ovary wall undergoes a series of complex changes to form fruit. In some fruits, such as soybeans, the ovary wall dries; in other fruits, such as grapes, it remains fleshy. In some cases, organs other than the ovary contribute to fruit formation; such fruits are called accessory fruits.
25.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Disease-related and psychosocial factors associated with difficult-to-manage and treatment-refractory axial spondyloarthritis: insights from the Greek AxSpA Registry.

Rheumatology international·2026
Same author

Post-EBV Cold Urticaria with High-Titre Cold Agglutinins without Haemolysis: A Paediatric Case Report.

Mediterranean journal of rheumatology·2026
Same author

No benefit of adding glucocorticoids to maintenance treatment in reducing the risk of major relapses in ANCA-associated vasculitis: real life data from a longitudinal cohort study.

RMD open·2026
Same author

Real-world efficacy and safety of ixekizumab from the joint psoriasis and psoriatic arthritis clinic.

Clinical and experimental dermatology·2026
Same author

Real-World Data From the Joint Psoriasis-Psoriatic Arthritis Clinic (PPAC) on the Efficacy of Bimekizumab in Patients With Psoriasis and Psoriatic Arthritis.

International journal of dermatology·2025
Same author

Mediterranean diet and exercise are associated with better disease control in psoriatic arthritis.

Clinical rheumatology·2024

Related Experiment Video

Updated: Jan 31, 2026

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

1.2K

Psoriatic Arthritis: Developments in 2025.

Christina Spanopoulou1, Pelagia Katsimbri1

  • 1Department of Rheumatology, KAT Hospital, Athens, Greece.

Mediterranean Journal of Rheumatology
|January 29, 2026
PubMed
Summary

Psoriatic arthritis (PsA) is a complex autoimmune disease. Recent advancements improve early diagnosis, risk identification, and personalized treatments, enhancing patient quality of life.

Keywords:
aetiologyantirheumatic agentsdisease managementincidencepsoriatic arthritistreatment outcome

More Related Videos

Author Spotlight: Isolation and Culture of Primary Synovial Macrophages and Fibroblasts from Murine Arthritis Tissue
09:18

Author Spotlight: Isolation and Culture of Primary Synovial Macrophages and Fibroblasts from Murine Arthritis Tissue

Published on: February 24, 2023

10.3K
In Vivo Optical Imaging of Brain Tumors and Arthritis Using Fluorescent SapC-DOPS Nanovesicles
09:04

In Vivo Optical Imaging of Brain Tumors and Arthritis Using Fluorescent SapC-DOPS Nanovesicles

Published on: May 2, 2014

11.8K

Related Experiment Videos

Last Updated: Jan 31, 2026

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

1.2K
Author Spotlight: Isolation and Culture of Primary Synovial Macrophages and Fibroblasts from Murine Arthritis Tissue
09:18

Author Spotlight: Isolation and Culture of Primary Synovial Macrophages and Fibroblasts from Murine Arthritis Tissue

Published on: February 24, 2023

10.3K
In Vivo Optical Imaging of Brain Tumors and Arthritis Using Fluorescent SapC-DOPS Nanovesicles
09:04

In Vivo Optical Imaging of Brain Tumors and Arthritis Using Fluorescent SapC-DOPS Nanovesicles

Published on: May 2, 2014

11.8K

Area of Science:

  • Rheumatology and Dermatology
  • Autoimmune Disease Research

Background:

  • Psoriatic arthritis (PsA) is a challenging autoimmune condition affecting skin and joints.
  • Its heterogeneous nature and comorbidities complicate diagnosis and treatment.
  • Early detection is crucial to prevent disability and achieve remission.

Purpose of the Study:

  • To review recent advancements in understanding psoriatic arthritis.
  • To highlight progress in risk identification and disease transition phases.
  • To discuss novel treatments and individualized management strategies.

Main Methods:

  • A narrative review of literature from major scientific databases.
  • Literature search conducted from June 2024 to September 2025.
  • Focus on advancements in PsA understanding, pathogenesis, and treatment.

Main Results:

  • Significant progress in identifying at-risk patients and transition phases from psoriasis (PsO) to PsA.
  • New insights into PsA pathogenesis have emerged.
  • Development of newer treatments and therapeutic protocols reported.

Conclusions:

  • Recent advancements facilitate a better understanding of PsA.
  • Individualized management protocols are being developed for improved patient outcomes.
  • Enhanced quality of life for PsA patients is a key goal.